Home Data Calendar Blog

MYGN

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Common Stock Value 0.800.800.800.800.800.800.800.800.800.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.720.730.730.740.740.770.810.800.810.810.830.840.840.850.860.860.90NA0.94NANA
Weighted Average Number Of Diluted Shares Outstanding 80.7080.4080.10NA81.5077.2076.0075.3074.700.0074.5074.4073.7074.8074.9076.5073.0072.9072.4071.9070.4068.9068.3068.3068.80NA73.5073.8072.10NA73.8775.4076.09NA76.3776.8381.80NA82.4384.2483.91NA86.4686.2387.04NA90.1393.6594.73NA99.6799.43
Weighted Average Number Of Shares Outstanding Basic 80.7080.4080.10NA78.8077.2076.0075.3074.700.0074.5074.4073.7073.4073.3074.2073.0070.1069.8069.3068.6068.2068.1068.2068.80NA70.9070.5068.70NA70.7072.4772.76NA73.8275.0779.58NA80.3881.6981.57NA84.4084.5085.24NA88.2191.5393.26NA96.8596.27
Earnings Per Share Basic -0.43-0.18-0.26-0.100.31-0.06-0.52-0.50-0.20-0.74-1.55-0.11-0.28-0.060.090.04-0.010.190.160.461.180.180.060.09-0.020.510.460.430.390.270.300.330.220.460.500.670.700.550.470.430.370.350.350.330.290.300.320.260.240.550.340.37
Earnings Per Share Diluted -0.43-0.18-0.26-0.100.30-0.06-0.52-0.50-0.20-0.74-1.55-0.11-0.28-0.060.090.03-0.010.180.160.451.150.180.060.09-0.020.490.440.410.370.260.290.320.210.430.480.660.680.540.460.420.360.340.340.330.290.300.310.260.240.540.330.36

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Revenue From Contract With Customer Excluding Assessed Tax 156.40179.30164.90160.80167.30189.40173.10154.60145.2093.20164.00195.10186.30215.40216.60216.80202.30200.90191.10192.70187.90199.60194.70196.70178.90173.10190.50193.30183.50189.28179.99184.39168.84188.77182.92204.06202.47174.12156.47149.14133.44132.97129.78122.81110.45107.41102.37100.4491.8693.9390.8392.77
Revenues 156.40179.30164.90160.80167.30189.40173.10154.60145.2093.20164.00195.10186.30215.40216.60216.80202.30200.90193.50194.00190.20199.60196.90196.50177.50186.40190.50193.30183.50189.88179.99184.39168.84188.77182.92204.06202.47174.12156.47149.14133.44132.97129.78122.81110.45107.41102.37100.4491.8693.9390.8392.77
Costs And Expenses 201.40197.10190.50203.90247.20210.20219.80202.80184.80161.50297.70203.90207.20221.00210.70210.70201.10185.00176.50189.60102.80180.70184.00183.30171.30150.80147.90148.10140.20153.69144.25148.05142.92135.51127.64121.06119.56108.2098.5593.5584.8685.6883.6877.3568.9865.6460.5561.8556.2756.3157.6058.25
Research And Development Expense 20.5020.3021.2020.5018.8019.5023.1018.2017.6017.4019.7018.8021.3020.9021.5022.4021.1017.7018.5016.8017.8018.8017.6018.6019.4019.5017.2016.7017.2018.7116.6717.5022.6120.1913.4017.0916.8014.5813.6214.1111.4012.1411.7510.248.519.236.676.095.765.255.885.06
Selling General And Administrative Expense 130.50127.10110.6077.30180.20134.80145.50132.80124.10107.40132.90135.60135.50149.80140.60135.20129.90121.40115.10115.40115.20122.10122.10120.30111.9091.3090.5090.8086.5096.5891.2892.6985.4484.3487.6377.8477.2871.5564.6059.5656.1356.5854.7050.9946.1143.8842.7543.7239.4939.8040.8442.10
Operating Income Loss -45.00-17.80-25.60-43.10-79.90-20.80-46.70-48.20-39.60-68.30-133.70-8.80-20.90-5.605.906.101.2015.9017.004.4087.4018.9012.9013.206.2035.6042.6045.2043.3036.2035.7436.3425.9253.2555.2983.0082.9065.9257.9255.5948.5847.2946.1045.4741.4741.7841.8238.5935.5937.6233.2334.52
Interest Expense 0.800.600.900.501.102.003.002.902.903.102.302.502.903.203.203.402.201.100.500.700.901.201.502.600.700.100.100.10NANANANANANANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 9.4010.4010.10NA10.008.909.00NA8.401.907.50NANANANANANANANANANANANANANANANANANA14.1312.5412.156.886.5713.646.866.93-19.556.73NANANANANANANANANANANANANA
Income Tax Expense Benefit -9.10-3.80-5.90-35.9015.200.90-10.10-12.50-28.50-3.00-15.90-3.10-1.70-3.40-3.601.001.603.005.20-28.405.605.803.806.205.201.5010.5014.7016.9016.8014.0913.919.8918.9220.5733.7828.3623.1521.3521.9519.6919.3317.8718.4916.7116.0714.3714.8613.64-14.651.230.98
Income Taxes Paid 0.600.700.302.200.70NANA0.501.300.600.20NA0.201.200.000.404.901.304.900.305.203.800.504.703.303.500.0010.1018.4016.409.901.7011.10NANANANANANANANANANANANANANANANANANANA
Profit Loss -35.10-14.10-20.50-7.6024.60-4.70-39.50-37.90-15.20-55.50-115.20-8.30-20.60-4.306.902.60-0.8013.1011.3032.1081.0012.104.205.90-1.2023.3034.5037.1030.30NANANANANANANANANANANANANANANANANANANANANANANA
Net Income Loss -35.10-14.10-20.50-7.6024.60-4.70-39.50-37.90-15.20-55.40-115.20-8.30-20.60-4.206.902.60-0.7013.1011.4032.1081.1012.304.205.90-1.2035.7032.6030.3026.6018.7121.4824.0315.9833.6336.7750.3655.4744.0737.8935.0430.1429.1429.6128.3025.1026.0427.9424.1922.5453.2533.2535.36
Comprehensive Income Net Of Tax -37.50-15.40-23.00-8.3024.20-5.10-40.80-36.60-13.60-52.80-117.80-6.10-22.80-3.906.203.30-0.500.7015.6031.9084.4017.907.50-2.502.7034.5033.4028.3026.5019.1818.1822.2215.1332.2436.1450.5054.6844.1137.6534.6930.4329.0829.7728.1624.8426.0927.9424.0322.66NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Assets 1212.001210.201255.401320.701335.901360.301336.901418.801444.501404.601446.701578.301591.201562.701557.301556.601573.601174.101218.501228.501228.301224.401267.801276.101270.90880.50868.20871.70787.00766.20779.05781.85809.01823.81816.43756.68781.66803.82729.03717.75703.06690.63699.25661.26611.74610.83557.28593.61NA593.85NANA
Liabilities 295.40262.80305.30352.90367.40457.90461.70537.80535.20486.40479.50501.00516.70473.80475.60492.50471.40209.20270.10314.30357.70446.60519.90543.40535.60132.4098.00100.9099.90104.10110.1587.6196.86104.8294.1880.7191.3975.2364.1055.6367.4954.9847.0644.4940.7444.0332.8232.51NA36.27NANA
Liabilities And Stockholders Equity 1212.001210.201255.401320.701335.901360.301336.901418.801444.501404.601446.701578.301591.201562.701557.301556.601573.601174.101218.501228.501228.301224.401267.801276.101270.90880.50868.20871.70787.00766.20779.05781.85809.01823.81816.43756.68781.66803.82729.03717.75703.06690.63699.25661.26619.74610.83557.28593.61NA593.85NANA
Stockholders Equity 916.60947.40950.10967.80968.60902.50875.20881.00909.30918.20967.201077.201074.501088.901081.801064.201102.20964.90948.30914.20870.90778.20748.20732.90735.50748.10770.20770.80687.10662.10668.90694.24712.15719.00722.24675.97690.27728.59664.93662.12635.57635.66652.19616.76578.99566.79524.46561.10NA557.58NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Assets Current 352.30367.10427.40484.80498.90538.90329.20389.40394.50331.70355.20365.30329.50348.60342.90336.80341.90326.40331.50327.00325.60317.10348.30341.60322.90314.50372.40375.50307.30283.60282.42320.09335.37322.42338.16454.51458.68483.99447.70457.33435.13422.49418.67432.44418.48418.26415.61444.81NA473.98NANA
Cash And Cash Equivalents At Carrying Value 110.70105.20165.20258.40295.20118.40148.90117.00118.30163.70121.0081.2089.9093.2084.9090.6093.30110.9097.4088.7087.90102.40123.80108.1086.9068.50120.50134.7087.4064.1055.2159.7169.8064.8285.8071.6084.99104.07112.3268.4295.5886.35104.85108.8562.6852.6867.3867.67123.3192.84102.1560.43
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 110.70105.20165.20258.40295.20118.40148.90117.00118.30163.70121.0081.2089.9093.2084.9090.6093.30110.90NANANA102.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Marketable Securities Current 82.5099.90103.2081.4070.9046.0027.2033.7042.1054.1060.5060.4052.7043.7064.8074.8074.2069.7059.9054.8060.4048.3048.3054.4061.5090.5096.2084.6068.0080.7079.22105.4189.81121.64126.36282.00272.03268.24223.83290.21253.58254.18232.51241.78286.85293.78293.85323.63NA310.39NANA
Accounts Receivable Net Current 102.20109.80101.7091.3093.6094.8094.1089.5085.1068.10102.50118.30117.00133.90142.60116.60119.1098.30123.70121.10113.20105.60114.80107.6098.2091.7091.1084.3083.4085.8092.1981.2275.7281.3082.6884.1486.2294.3393.1775.5662.5060.4450.9542.9944.8250.2746.4440.06NA47.80NANA
Inventory Net 19.6015.4015.6015.3018.6017.7024.6027.1026.6029.1030.8028.1028.1031.4031.9033.3035.9034.3033.4038.2038.9042.2047.4051.3053.9038.3025.3029.1034.3025.1029.3620.1724.7723.9218.91NANA5.017.1410.4710.6011.5710.3810.299.708.22NANANANANANA
Prepaid Expense And Other Assets Current 19.5017.6022.9020.0020.2017.70NA13.70NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Property Plant And Equipment Gross 176.00158.40149.10150.40148.40146.10155.80153.60146.70143.90142.30143.80167.00169.20167.80NA164.50157.10156.80154.80150.70148.40146.30144.60143.30141.70141.70139.20139.50138.10136.63114.26108.5999.6195.5391.9689.1084.2081.0779.5975.2172.5370.7669.2066.1364.1168.28NANA65.27NANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 108.50105.60103.40106.90105.00102.90110.70112.90110.00106.90105.20107.30112.00111.90109.10NA104.50113.90108.60106.40100.9097.3093.3089.9086.5083.4081.7077.5074.6070.9067.5367.8065.1665.0162.8760.6558.4356.5954.2052.3150.4548.3046.6644.8742.8841.0346.9445.35NA42.01NANA
Amortization Of Intangible Assets 10.2010.2010.2010.1011.6013.5015.5015.5015.3015.2015.3015.2015.3015.3015.2015.4013.409.309.309.309.309.309.209.305.503.203.103.203.203.083.143.133.353.001.150.240.240.190.190.230.280.280.280.280.28NANANANANANANA
Property Plant And Equipment Net 67.5052.8045.7043.5043.4043.2045.1040.7036.7037.0037.1036.5055.0057.3058.7059.1060.0043.2048.2048.4049.8051.1053.0054.7056.8058.3060.0061.7064.9067.2069.1046.4643.4234.5932.6631.3130.6827.6026.8827.2924.7624.2324.1024.3323.2623.0821.34NANA23.26NANA
Goodwill 236.50237.80238.80239.20239.70240.10328.30329.20328.30327.60327.10408.10416.10417.20415.90413.20413.30318.60320.20319.40319.00316.10315.00315.40312.80195.30177.90177.00177.30177.20185.23169.18169.18169.18166.7556.8556.8556.8556.8556.8556.8556.8556.8556.8556.8556.05NANANANANANA
Intangible Assets Net Excluding Goodwill 370.80382.30393.60404.10414.80426.80559.90576.50590.90605.30620.00653.50667.80684.70699.50717.60734.20455.20467.30475.20483.80491.60498.10506.40521.20227.50183.20186.30189.40192.60195.69198.83201.96205.31208.3012.8413.0913.3313.5313.7215.4515.7215.9916.2716.4416.71NANANA2.05NANA
Other Assets Noncurrent 8.308.808.208.308.004.803.602.301.20NANANANANANANANANANANANANANA2.505.005.005.005.005.005.005.005.005.005.005.00NANA13.00NANANANANANANANA1.911.99NA2.05NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Liabilities Current 129.10119.70166.00204.30203.20271.00149.00145.90133.70147.00113.20112.40115.40117.80108.90113.30108.00102.2094.30159.30139.20217.50221.7082.80274.9072.3066.1065.9059.0068.7067.1759.8467.7280.5872.1667.3979.0364.5153.6245.4957.3644.9737.0535.0531.2934.3923.3723.19NA27.47NANA
Accounts Payable Current 29.6021.7027.1029.6015.7028.5020.8020.5019.1021.7030.3021.0024.0033.3024.1031.9023.8026.0020.2025.1022.5022.0026.8022.9019.9021.1013.8016.5015.8021.1017.9516.8325.7323.0818.9317.6018.7518.1312.2413.5711.0910.147.948.889.8311.395.197.05NA8.87NANA
Other Accrued Liabilities Current 20.5020.8017.5019.3021.5017.5029.6018.4014.7022.404.308.2011.5018.0021.6017.7018.8014.5012.4015.6014.0014.1011.7013.7014.609.408.808.807.908.50NANANA9.40NANANANANANANANANANANANANANANANANANA
Taxes Payable Current 3.803.904.104.0017.303.705.404.303.506.103.504.007.203.003.804.909.804.302.903.208.607.103.003.003.202.802.304.704.003.80NANANA6.20NANANANANANANANANANANANANANANANANANA
Accrued Liabilities Current 85.3084.40124.80156.50163.2090.9083.1079.1065.4075.9063.1061.1073.0078.9078.8073.7076.4068.3064.1060.8059.8065.6064.0057.7054.8049.5050.8047.9041.8046.1047.8841.1840.6556.4151.1045.8459.3944.3338.3529.1942.9932.7727.7323.7420.3821.6418.1816.14NA18.60NANA
Contract With Customer Liability Current 0.200.300.705.2011.5022.6031.1032.7032.3032.803.803.602.102.202.302.402.502.602.603.402.902.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Deferred Income Tax Liabilities Net 10.5023.3029.9035.8040.7058.2059.2071.3075.3026.60NANANA82.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Noncurrent 4.604.704.905.6010.8013.8019.3014.7010.704.30NANA7.307.807.306.606.306.306.806.607.407.2021.50145.901.1012.302.002.002.208.80NANANA0.00NANANANANANANANANANANANANANANANANANA
Operating Lease Liability Noncurrent 123.3087.4076.5079.3080.7083.9049.4050.6053.5056.9055.9058.7062.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Stockholders Equity 916.60947.40950.10967.80968.60902.50875.20881.00909.30918.20967.201077.201074.501088.901081.801064.201102.20964.90948.30914.20870.90778.20748.20732.90735.50748.10770.20770.80687.10662.10668.90694.24712.15719.00722.24675.97690.27728.59664.93662.12635.57635.66652.19616.76578.99566.79524.46561.10NA557.58NANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 916.60947.40950.10967.80968.50902.40875.20881.00909.30918.20967.201077.301074.501088.901081.701064.101102.20964.90948.40914.20870.60777.80747.90732.70735.30748.10NANANANANANANANANANANANANANANANANANANANANANANANANANA
Common Stock Value 0.800.800.800.800.800.800.800.800.800.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.700.720.730.730.740.740.770.810.800.810.810.830.840.840.850.860.860.90NA0.94NANA
Additional Paid In Capital Common Stock 1251.001244.301231.601226.301218.801176.901144.501109.501101.201096.601092.801085.101076.301068.001057.001045.601052.40915.40889.60871.10859.60851.40839.50831.80826.90830.10847.00847.80772.30745.40NANANANANANANANANANANANANANANANANANANANANANA
Retained Earnings Accumulated Deficit -323.90-288.80-274.70-254.20-246.60-271.20-266.50-227.00-189.10-173.90-118.50-3.305.0025.6029.8022.9053.4052.9056.2044.8012.80-68.40-81.40-85.70-86.50-73.20-69.20-68.60-78.80-77.00-62.28-36.98-17.452.0018.8611.6013.9630.872.05-4.27-15.00-12.68-0.09-21.43-38.30-38.63-48.08-20.66NA-10.46NANA
Accumulated Other Comprehensive Income Loss Net Of Tax -11.30-8.90-7.60-5.10-4.40-4.00-3.60-2.30-3.60-5.20-7.80-5.30-7.50-5.40-5.70-5.00-4.30-4.101.80-2.40-2.20-5.50-10.60-13.90-5.60-9.50-8.30-9.10-7.10-7.00-7.56-4.18-2.37-1.51-0.120.510.36-0.42-0.46-0.220.13-0.16-0.10-0.25-0.110.150.100.10NA0.14NANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 9.4010.4010.10NA10.008.909.006.508.401.907.507.008.80NA9.507.507.70NA6.606.906.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Net Cash Provided By Used In Operating Activities -1.80-50.30-46.50-9.90-39.30-4.4071.80-14.40-59.3030.0016.80-1.9015.8031.506.6037.807.8047.9011.5033.0023.50NANANANANANANANANANANANANA11.2547.5590.4863.0037.4022.1151.3641.7440.7127.5431.8636.3028.0437.1229.3046.5242.66NA
Net Cash Provided By Used In Investing Activities 11.40-12.00-41.30-25.90291.001.108.2010.9017.1010.3023.20-7.20-7.104.50-3.80-8.10-279.008.90-0.70-4.60-15.20NANANANANANANANANANANANANA-0.4710.72-8.06-84.6348.08-34.04-5.00-8.17-43.8215.63-2.53-60.9442.48-52.6016.6711.97-13.43NA
Net Cash Provided By Used In Financing Activities -3.602.50-4.80-1.10-74.50-26.50-48.501.80-3.901.000.201.10-12.30-27.80-9.40-32.60252.10-41.30-4.30-26.10-23.30NANANANANANANANANANANANANA3.42-71.66-101.5113.38-41.58-15.24-37.12-52.03-0.933.01-19.309.87-70.81-40.16-15.50-67.8012.49NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Net Cash Provided By Used In Operating Activities -1.80-50.30-46.50-9.90-39.30-4.4071.80-14.40-59.3030.0016.80-1.9015.8031.506.6037.807.8047.9011.5033.0023.50NANANANANANANANANANANANANA11.2547.5590.4863.0037.4022.1151.3641.7440.7127.5431.8636.3028.0437.1229.3046.5242.66NA
Net Income Loss -35.10-14.10-20.50-7.6024.60-4.70-39.50-37.90-15.20-55.40-115.20-8.30-20.60-4.206.902.60-0.7013.1011.4032.1081.1012.304.205.90-1.2035.7032.6030.3026.6018.7121.4824.0315.9833.6336.7750.3655.4744.0737.8935.0430.1429.1429.6128.3025.1026.0427.9424.1922.5453.2533.2535.36
Profit Loss -35.10-14.10-20.50-7.6024.60-4.70-39.50-37.90-15.20-55.50-115.20-8.30-20.60-4.306.902.60-0.8013.1011.3032.1081.0012.104.205.90-1.2023.3034.5037.1030.30NANANANANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Receivable -6.108.4010.50-2.80-0.707.604.704.4017.00-34.50-15.903.10-16.70-8.8026.10-2.403.30-3.109.8016.0016.501.1015.9018.505.9010.5017.607.503.602.1618.3512.371.527.075.718.223.3811.3525.9820.599.2616.7614.854.52-1.184.0210.160.420.394.423.84NA
Increase Decrease In Inventories 4.30-0.100.20-3.200.803.20-2.400.40-2.60-1.702.600.50-3.10-0.60-1.30-2.60-3.501.00-4.80-0.80-3.30-5.30-3.90-2.6013.0014.40-3.90-5.109.20-4.128.62-4.600.905.40NANANA-2.13-3.33-0.14-0.971.250.070.621.49NANANANANANANA
Increase Decrease In Accounts Payable 7.10-5.00-3.2014.00-12.907.800.302.00-3.20-8.609.20-2.00-9.309.20-7.808.10-8.406.00-5.002.600.40-5.004.003.00-5.00NA-2.801.20-5.303.30-0.15-8.892.654.14-5.10-1.150.615.89-1.342.490.942.21-0.95-0.93-1.583.97-1.86-0.19-1.631.84-2.38NA
Share Based Compensation 9.4010.4010.108.4010.008.909.006.508.401.907.507.008.808.809.507.507.707.106.606.906.407.207.507.407.807.707.607.708.7014.1312.5012.106.886.576.716.866.936.186.737.116.606.426.596.616.666.376.226.126.375.804.98NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Net Cash Provided By Used In Investing Activities 11.40-12.00-41.30-25.90291.001.108.2010.9017.1010.3023.20-7.20-7.104.50-3.80-8.10-279.008.90-0.70-4.60-15.20NANANANANANANANANANANANANA-0.4710.72-8.06-84.6348.08-34.04-5.00-8.17-43.8215.63-2.53-60.9442.48-52.6016.6711.97-13.43NA
Payments To Acquire Productive Assets 17.706.706.303.403.004.507.106.401.502.403.003.401.401.403.102.801.301.802.902.101.600.701.502.401.502.200.701.101.002.004.465.9511.504.621.552.835.262.791.574.552.462.192.003.112.110.610.161.061.960.831.15NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Net Cash Provided By Used In Financing Activities -3.602.50-4.80-1.10-74.50-26.50-48.501.80-3.901.000.201.10-12.30-27.80-9.40-32.60252.10-41.30-4.30-26.10-23.30NANANANANANANANANANANANANA3.42-71.66-101.5113.38-41.58-15.24-37.12-52.03-0.933.01-19.309.87-70.81-40.16-15.50-67.8012.49NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31
Revenues 156.40179.30164.90160.80167.30189.40173.10154.60145.2093.20164.00195.10186.30215.40216.60216.80202.30200.90193.50194.00190.20199.60196.90196.50177.50186.40190.50193.30183.50189.88179.99184.39168.84188.77182.92204.06202.47174.12156.47149.14133.44132.97129.78122.81110.45107.41102.37100.4491.8693.9390.8392.77
Revenue From Contract With Customer Excluding Assessed Tax 156.40179.30164.90160.80167.30189.40173.10154.60145.2093.20164.00195.10186.30215.40216.60216.80202.30200.90191.10192.70187.90199.60194.70196.70178.90173.10190.50193.30183.50189.28179.99184.39168.84188.77182.92204.06202.47174.12156.47149.14133.44132.97129.78122.81110.45107.41102.37100.4491.8693.9390.8392.77
Molecular Diagnostic Autoimmune 0.000.000.300.007.3010.2010.708.909.107.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Hereditary Cancer Testing 70.5079.4070.9074.8079.4086.0076.1078.7080.6039.9085.20117.70104.50119.00117.60126.70116.30119.20113.10122.20117.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Pharmacogenomics 33.0033.1029.3029.4024.1022.6017.6017.9011.908.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Prenatal Testing 22.1033.3031.9030.1023.6029.4023.7021.1016.5016.6020.3016.4023.5024.9030.6031.2018.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Testing 156.40179.30164.90160.80167.30178.70159.60143.90135.7083.30150.50181.10172.00196.90200.50203.00189.00187.60177.30177.90176.50187.00183.00184.10166.50NANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Tumor Profiling 30.8033.5032.5026.5032.9029.2031.0016.9017.0010.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Autoimmune,US 0.000.000.300.007.3010.2010.708.909.107.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Hereditary Cancer Testing,US 60.2069.8060.7063.9068.2073.8065.1068.8072.1034.9081.30112.90100.60115.30114.30123.40113.50NA110.40119.60114.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Hereditary Cancer Testing, Non Us 10.309.6010.2010.9011.2012.2011.009.908.505.003.904.803.903.703.303.302.80NA2.702.602.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Pharmacogenomics,US 33.0033.1029.3029.4024.1022.6017.6017.9011.908.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Prenatal Testing,US 21.9033.1031.7029.9023.5029.2023.6021.0016.4016.5020.2016.3023.5024.9030.6031.2018.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Prenatal Testing, Non Us 0.200.200.200.200.100.200.100.100.100.100.100.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Testing,US 135.30157.50141.70139.70144.50154.10141.20130.80124.5076.30143.40174.00166.20191.20194.70197.60184.00NA164.30168.40163.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Testing, Non Us 21.1021.8023.2021.1022.8024.6018.4013.1011.207.007.107.105.805.705.805.405.00NA5.004.704.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Tumor Profiling,US 20.2021.5019.7016.5021.4018.1024.2013.8014.408.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Molecular Diagnostic Tumor Profiling, Non Us 10.6012.0012.8010.0011.5011.106.803.102.601.90NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
US 135.30157.50141.70139.70144.50164.80154.70141.40134.0086.20153.00182.30174.70203.50204.40205.80191.60182.50171.30177.30169.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Non Us 21.1021.8023.2021.1022.8024.6018.4013.2011.207.0011.0012.9011.7011.9012.2011.0010.7011.4011.8010.609.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Inventory Net
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Liabilities Current
Current Liabilities
Contract With Customer Liability Current
Noncurrent Liabilities
Other Liabilities Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementGeographical
(None, 'US')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:CashAndCashEquivalents
(None,)
Cash And Cash Equivalents At Carrying Valueus-gaap: Cash And Cash Equivalents
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:InvestmentType
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementGeographical
(None, 'US')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Geographical
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical